Evaluation of Antidiabetic Drug use Profile in Outpatients at A Private Hospital in Bandar Lampung City
DOI:
10.29303/jbt.v26i2.11846Published:
2026-04-20Downloads
Abstract
Diabetes mellitus is a long-lasting metabolic condition marked by high blood sugar levels resulting from insufficient insulin production. This study aims to evaluate the profile of antidiabetic drug use in outpatients with diabetes mellitus at a private hospital in Bandar Lampung and assess its compliance with current treatment guidelines. This study employed a non-experimental method with a retrospective descriptive design based on medical records and outpatient prescriptions from January to July 2025. The data analyzed included gender, age, comorbidities, and the types of antidiabetic drugs used. The results showed that type 2 diabetes mellitus patients were more prevalent in women (60.78%) than in men (39.22%), with the largest group of diabetes mellitus patients falling within the 45–60 age group. Most patients also had comorbidities, with hypertension being the most common. The pattern of medication use showed that biguanides, particularly metformin, were the most commonly prescribed drugs as first-line therapy. In general, the use of antidiabetic drugs in outpatients at the hospital was in accordance with the PERKENI treatment guidelines.
Keywords:
Antidiabetic drug Diabetes melitus Drug utilization evaluation Outpatients PERKENIReferences
Bella, S., Nurmainah, N., & Andrie, M. (2022). Analisis Persistensi Penggunaan Obat Antidiabetik Terhadap Pencapaian Gula Darah Optimal Pada Pasien di Puskesmas. Journal Syifa Sciences and Clinical Research, 4(3). https://doi.org/10.37311/jsscr.v4i3.15371
Cahyaningsih, O. I., Dini, I. R. E., & Hardian, H. (2021). Gambaran Peresepan Metformin pada Pasien Diabetes Melitus Tipe 2 di Rumah Sakit Nasional Diponegoro Semarang. Generics: Journal of Research in Pharmacy, 1(2), 37–43. https://doi.org/10.14710/genres.v1i2.11124
Damayanti, V. W., Yonata, A., & Kurniawaty, E. (2023). Hipertensi pada Diabetes Melitus: Patofisiologi dan Faktor Risiko. MEDICAL PROFESSION JOURNAL OF LAMPUNG, 13(07), 1253–1257. https://doi.org/10.53089/medula.v13i7.896
Faida, A. N., & Santik, Y. D. P. (2020). Kejadian Diabetes Melitus Tipe I pada Usia 10-30 Tahun. D. P. S., 04(01), 33–42.
Hakim, A., Ismunandar, H., Wahyuni, A., & Sangging, P. R. A. (2022). Manajemen Diabetes Melitus: An Update. MEDICAL PROFESSION JOURNAL OF LAMPUNG, Vol. 12 No. 1 (2022): Medula, 12(1), 160–165. https://doi.org/10.53089/medula.v12i1.388
Kurniawati, T., Lestari, D., Rahayu, A. P., Syaputri, F. N., & Tugon, T. D. A. (2021). Evaluasi Profil Penggunaan Obat Antidiabetes Pada PasienDiabetesMelitus Tipe 2 Rawat Jalan di Salah Satu Rumah Sakit KabupatenBogor. Journal od Science, Technology, and Entrepreneurship, 3(Vol: 3 No: 1 Tahun: 2021), 24–34.
Kusumawati, N. N., & Andayani, T. M. (2024). Review: Cost-Effectiveness Analysis Metformin dan Dipeptidyl Peptidase-4 Inhibitor Dibandingkan dengan Metformin dan Sulfonilurea pada Pasien Diabetes Melitus Tipe 2. JPSCR: Journal of Pharmaceutical Science and Clinical Research, 9(2), 325. https://doi.org/10.20961/jpscr.v9i2.91911
Milita, F., Handayani, S., & Setiaji, B. (2021). Kejadian Diabetes Mellitus Tipe II pada Lanjut Usia di Indonesia (Analisis Riskesdas 2018). Jurnal Kedokteran dan Kesehatan, 17(1), 9. https://doi.org/10.24853/jkk.17.1.9-20
Mola, M. M., Purwanggana, A., Subhan, A., & Widyastuti, A. A. A. (2025). Evaluasi Penggunaan Obat Antidiabetik Pasien Geriatri Diabetes Melitus Tipe 2 Rawat Inap Jalan RSUP Fatmawati Jakarta Selatan Tahun 2023. Jurnal Farmasi Klinik Best Practice, 4(2), 14–28. https://doi.org/10.58815/jfklin.v4i2.68
Pagedongan, D. N. P., & Astuti, K. W. (2025). Efektivitas Terapi Kombinasi Metformin dan Glimepiride pada Pasien Diabetes Mellitus Tipe 2: Tinjauan Literatur. Jurnal Praba : Jurnal Rumpun Kesehatan Umum, 3(3), 13–24. https://doi.org/10.62027/praba.v3i3.493
Ramdini, D. A., Wahidah, L. K., & Atika, D. (2020). Evaluasi Rasionalitas Penggunaan Obat Diabetes Melitus Tipe Ii Pada Pasien Rawat Jalan Di Puskesmas Pasir Sakti Tahun 2019. JFL : Jurnal Farmasi Lampung, 9(1), 67–76. https://doi.org/10.37090/jfl.v9i1.334
Rusli, R., Nurisyah, N., Dewi, R., Rianti, A. E., & Khafifah, K. (2024). Kesesuaian Penggunaan Obat Pada Pasien Diabetes Melitus Berdasarkan Algoritma Terapi Di Wilayah Kerja Puskesmas Andalas Dan Puskesmas Tarakan Kota Makassar. Jurnal Media Analis Kesehatan, 15(2), 112–123. https://doi.org/10.32382/jmak.v15i2.1074
Utomo, A. A., Aulia R, A., Rahmah, S., & Amalia, R. (2020). Faktor Risiko Diabetes Mellitus Tipe 2: A Systemic Review. AN-Nur: Jurnal Kajian dan Pengembangan Kesehatan Masyarakat, 01(01), 44–53.
Widiasari, K. R., Wijaya, I. M. K., & Suputra, P. A. (2021). Diabetes Melitus Tipe 2: Faktor Risiko, Diagnosis, Dan Tatalaksana. Ganesha Medicina, 1(2), 114. https://doi.org/10.23887/gm.v1i2.40006
Wulandari, A., & Melati, R. S. (2021). Kesesuaian penggunaan obat antidiabetes pada pasien diabetes melitus di puskesmas x Palembang. Borneo Journal of Pharmascientech, 5(2), 73–90. https://doi.org/10.51817/bjp.v5i2.388
Saputri, D. G., Putri, C. A., Ramandani, C., Sugesti, D., Andini, A. D., Haqiqi, C. A. D., & Arini, L. D. D. (2025). Diabetes Melitus sebagai Gangguan Endokrin: Tinjauan Patofisiologi dan Pendekatan Diagnosis. Jejak digital: Jurnal Ilmiah Multidisiplin, 1(6), 4382-4387.
Uchira, U., Kasim, J., & Rasdin, R. (2024). Upaya Preventif Lansia pada Penyakit Diabetes Melitus. Dinamika Sosial: Jurnal Pengabdian Masyarakat dan Transformasi Kesejahteraan, 1(4), 183-190.
Santoso, A. H., Rumawas, M. E., Limanan, D., Akhmad, F. A. K., Putra, H. Y., Marcellino, M., & Teguh, S. K. M. M. (2024). Pencegahan diabetes melalui pemeriksaan gula darah dan konseling pada masyarakat dewasa usia produktif di Jakarta Barat. Jurnal Bakti Masyarakat Indonesia, 7(1), 94-102.
Pulungan, A. B., Annisa, D., & Imada, S. (2019). Diabetes melitus tipe-1 pada anak: Situasi di Indonesia dan tata laksana. Sari Pediatri, 20(6), 392-400.
License
Copyright (c) 2026 Frenca Elsa Sitanala, Louis Madalena, Marvel Reuben Suwitono
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
